Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Black Diamond Therapeutics Inc

BDTX
Current price
2.36 USD 0 USD (0.00%)
Last closed 2.36 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 121 859 064 USD
Yield for 12 month +26.88 %
Week
Month
Year
BDTX
21.11.2021 - 28.11.2021

Black Diamond Therapeutics, Inc., a clinical-stage precision oncology medicine company, focuses on the discovery and development of therapies for patients with genetically defined cancers. The company's lead product candidate, BDTX-1535, a brain-penetrant, mutant selective, irreversible EGFR MasterKey inhibitor, designed to inhibit a family of oncogenic mutations, currently under Phase 1 clinical trial. It also develops BDTX-4933, a brain penetrant RAF MasterKey inhibitor, designed to be a brain penetrant and highly selective and potent inhibitor of oncogenic BRAF Class I, II, III and active RAF dimers, expected to initiate Phase 1 clinical trial. The company was formerly known as ASET Therapeutics, Inc. and changed its name to Black Diamond Therapeutics, Inc. in January 2018. Black Diamond Therapeutics, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts. Address: One Main Street, Cambridge, MA, United States, 02142

Analytics

WallStreet Target Price

11.33 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

Current Quarter

Last Quarter

Key Figures BDTX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -86 980 000 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -30.99 %
PEG Ratio
Return On Equity TTM -62.88 %
Wall Street Target Price 11.33 USD
Revenue TTM
Book Value 2.6 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings Share -2.13 USD
Diluted Eps TTM -2.13 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics BDTX

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History BDTX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation BDTX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -0.0368
Price Book MRQ 0.9034

Financials BDTX

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators BDTX

For 52 weeks

1.22 USD 6.85 USD
50 Day MA 2.28 USD
Shares Short Prior Month 3 350 852
200 Day MA 2.56 USD
Short Ratio 4.8
Shares Short 3 360 159
Short Percent 10.37 %